Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

Leiter, Ulrike; Stadler, Rudolf; Mauch, Cornelia; Hohenberger, Werner; H. Brockmeyer, Norbert; Berking, Carola; Sunderkötter, Cord; Kaatz, Martin; Schatton, Kerstin; Lehmann, Percy; Vogt, Thomas; Ulrich, Jens; Herbst, Rudolf; Gehring, Wolfgang; Simon, Jan‐Christoph; Keim, Ulrike; Verver, D.; Martus, Peter; Garbe, Claus; behalf of the German Dermatologic Cooperative Oncology Group, on

doi:10.1200/jco.18.02306

Public

Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node

Published in Journal of Clinical Oncology • Sep 26, 2019

Authors:

Ulrike Leiter

Rudolf Stadler

Cornelia Mauch

Abstract

PURPOSE We have previously reported on the 3-year results of the phase III German Dermatologic Cooperative Oncology Group trial (DeCOG; ClinicalTrials.gov identifier: NCT02434107 ) comparing distant metastasis-free survival (DMFS), recurrence-free survival (RFS), and overall survival (OS) in patient...

Subject

Medicine

Interquartile range

Lymph node

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!